m6A-mRNA Methylation Regulates Gene Expression and Programmable m6A Modification of Cellular RNAs With CRISPR-Cas13b in Renal Cell Carcinoma
Background: N6-methyladenosine (m6A) is the most extensive messenger RNA modification. Despite recent advances in the biological roles of m6A, its role in the development and progression of renal cell carcinoma (RCC) remains unclear.Methods: In this study, we gained the transcriptome-wide m6A profil...
Main Authors: | Ying Gan, Aolin Li, Jun Liu, Xiaofei Wang, Zhenan Zhang, Qinhan Li, Xiongjun Ye, Lin Yao, Qian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.795611/full |
Similar Items
-
Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma
by: Congcong Cao, et al.
Published: (2021-06-01) -
ZNF677 suppresses renal cell carcinoma progression through N6‐methyladenosine and transcriptional repression of CDKN3
by: Aolin Li, et al.
Published: (2022-06-01) -
m6A Methylation-Mediated Stabilization of LINC01106 Suppresses Bladder Cancer Progression by Regulating the miR-3148/DAB1 Axis
by: Jun Liu, et al.
Published: (2024-01-01) -
Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems
by: Lin Yao, et al.
Published: (2020-12-01) -
RNA-dependent RNA targeting by CRISPR-Cas9
by: Steven C Strutt, et al.
Published: (2018-01-01)